Can reminders and feedback curb antibiotic overuse in ghanaian pharmacies?

NCT ID NCT07284914

First seen Dec 29, 2025 · Last updated Jun 22, 2026 · Updated 25 times

Summary

This study tests two simple interventions aimed at community pharmacies in Ghana: giving them personalized feedback on their antibiotic dispensing habits and sending a legal reminder that selling antibiotics without a prescription is illegal. Researchers will track whether these steps reduce the number of antibiotics given out without a doctor's order. The goal is to gather evidence to help design future policies against antimicrobial resistance.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for UPPER RESP TRACT INFECTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University of Ghana, Regional Institute for Population Studies

    Legon, Ghana

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could provide evidence for policies that reduce unnecessary antibiotic use and help slow antimicrobial resistance in Ghana.

What could go wrong

This is a behavioral study with no direct medical treatment, so results may not apply to other regions or lead to immediate change. The interventions are simple reminders and feedback, which may have limited impact.

Conditions

The condition(s) this trial relates to.

respiratory tract infectious disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.